Artificial Intelligence3 years ago
Envisagenics Raises Series A Financing to Scale Its AI-powered RNA Splicing Drug Discovery Platform
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA splicing therapeutics, secured Series A financing to scale its drug...